VAR News and Press, Varian Medical Systems Inc. From 10/19/20

Merger activity moderated again last week with three new deals announced. The acquisition of Acorn International by First Ostia Port. The merger of DouYu International Holdings Limited and HUYA Inc. For further details see: Merger Arbitrage Mondays - 2 Potential Deals Co...

Varian Announces Fourth Quarter Fiscal Year 2020 Earnings Release Date PR Newswire PALO ALTO, Calif., Oct. 16, 2020 PALO ALTO, Calif. , Oct. 16, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced its fourth quarter of fiscal year 2020 earnings relea...

Varian Stockholders Approve Combination with Siemens Healthineers PR Newswire PALO ALTO, Calif., Oct. 15, 2020 PALO ALTO, Calif. , Oct. 15, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that its stockholders have voted to approve the previously...

Varian (VAR) has received an Investigational Device Exemption (‘IDE’) from the Food and Drug Administration for the first-ever clinical trial of FLASH therapy.FLASH therapy, involving ultra-high dose rates, and delivery in typically less than one second, may be over 100 times fa...

Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy The FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases) study is a significant milestone in the development of FLASH ...

Siemens Healthineers' proposed acquisition of Varian still makes sense, even if the market hasn't loved it, and will add a complementary quality growth driver to the business. After several years of underperformance and share loss, the diagnostics business needs a concerted turnaround...

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to John...

NEW YORK, NY / ACCESSWIRE / September 20, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc . ( AKCA ) relating t...

NEW YORK, NY / ACCESSWIRE / September 19, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Maxim Integrated Products, Inc. (NASDAQ: MXIM...

NEW YORK , Sept. 18, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP...